Stability of F-box protein atrogin-1 is regulated by p38 mitogen-activated protein kinase pathway in cardiac H9c2 cells

Cellular Physiology and Biochemistry

Volumn 27, Issue 5, 2011, Pages 463-470

  Li, Jun Jie ^a   Zhang, Tian Peng ^a   Meng, Yan ^b   Du, Jie ^c   Li, Hui Hua ^b  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Atrogin 1 MAFbx; Degradation; p38 MAPK; Ubiquitination

Indexed keywords

ATROGIN 1; F BOX PROTEIN; F BOX PROTEIN CUL1; F BOX PROTEIN ROC1; F BOX PROTEIN SKP1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEASOME; UNCLASSIFIED DRUG;

ARTICLE; CELL SIZE; CONTROLLED STUDY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; REGULATORY MECHANISM; UBIQUITINATION; WESTERN BLOTTING;

EID: 79959475154     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000329967     Document Type: Article

References (36)

1. Thompson SJ, Loftus LT, Ashley MD, Meller R: Ubiquitin-proteasome system as a modulator of cell fate. Curr Opin Pharmacol 2008;8:90-95. (Pubitemid 351168692)
2. Pickart CM, Eddins MJ: Ubiquitin: Structures, functions, mechanisms. Biochim Biophys Acta 2004;1695:55-72. (Pubitemid 39585154)
3. Strack P, Caligiuri M, Pelletier M, Boisclair M, Theodoras A, Beer-Romero P, Glass S, Parsons T, Copeland RA, Auger KR, Benfield P, Brizuela L, Rolfe M: Scf(beta-trcp) and phosphorylation dependent ubiquitinationof i kappa b alpha catalyzed by ubc3 and ubc4. Oncogene 2000;19:3529-3536. (Pubitemid 30487450)
4. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ: Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001;294:1704-1708. (Pubitemid 33104839)
5. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL: Atrogin-1, a musclespecific f-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 2001;98:14440-14445. (Pubitemid 33121410)
6. Li HH, Kedar V, Zhang C, McDonough H, Arya R, Wang DZ, Patterson C: Atrogin-1/muscle atrophy f-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an scf ubiquitin ligase complex. J Clin Invest 2004;114:1058-1071. (Pubitemid 39578695)
7. Li HH, Willis MS, Lockyer P, Miller N, McDonough H, Glass DJ, Patterson C: Atrogin-1 inhibits akt-dependent cardiac hypertrophy in mice via ubiquitindependent coactivation of forkhead proteins. J Clin Invest 2007;117:3211-3223. (Pubitemid 350096979)
8. Csibi A, Leibovitch MP, Cornille K, Tintignac LA, Leibovitch SA: Mafbx/atrogin-1 controls the activity of the initiation factor eif3-f in skeletal muscle atrophy by targeting multiple c-terminal lysines. J Biol Chem 2009;284:4413-4421.
9. Tintignac LA, Lagirand J, Batonnet S, Sirri V, Leibovitch MP, Leibovitch SA: Degradation of myod mediated by the scf (mafbx) ubiquitin ligase. J Biol Chem 2005;280:2847-2856. (Pubitemid 40189393)
10. Xie P, Guo S, Fan Y, Zhang H, Gu D, Li H: Atrogin-1/mafbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of mapk phosphatase-1 and sustained jnk activation. J Biol Chem 2009;284:5488-5496.
11. Adams V, Linke A, Wisloff U, Doring C, Erbs S, Krankel N, Witt CC, Labeit S, Muller-Werdan U, Schuler G, Hambrecht R: Myocardial expression of murf-1 and mafbx after induction of chronic heart failure: Effect on myocardial contractility. Cardiovasc Res 2007;73:120-129. (Pubitemid 44937197)
12. Glass DJ: Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 2005;37:1974-1984. (Pubitemid 41206815)
13. Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL, Reid MB: Tnf-alpha acts via p38 mapk to stimulate expression of the ubiquitin ligase atrogin1/mafbx in skeletal muscle. Faseb J 2005;19:362-370. (Pubitemid 40316524)
14. Li YP, Chen Y, Li AS, Reid MB: Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific e2 and e3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol 2003;285:C806-812. (Pubitemid 37158805)
15. Li YP, Lecker SH, Chen Y, Waddell ID, Goldberg AL, Reid MB: Tnf-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating ubch2/e220k. Faseb J 2003;17:1048-1057. (Pubitemid 36676391)
16. Zechner D, Craig R, Hanford DS, McDonough PM, Sabbadini RA, Glembotski CC: Mkk6 activates myocardial cell nf-kappab and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J Biol Chem 1998;273:8232-8239. (Pubitemid 28168880)
17. Fan Y, Xie P, Zhang T, Zhang H, Gu D, She M, Li H: Regulation of the stability and transcriptional activity of nfatc4 by ubiquitination. FEBS Lett 2008;582:4008-4014.
18. Li Y, Gazdoiu S, Pan ZQ, Fuchs SY: Stability of homologue of slimb f-box protein is regulated by availability of its substrate. J Biol Chem 2004;279:11074-11080. (Pubitemid 38401599)
19. Wirbelauer C, Sutterluty H, Blondel M, Gstaiger M, Peter M, Reymond F, Krek W: The f-box protein skp2 is a ubiquitylation target of a cul1-based core ubiquitin ligase complex: Evidence for a role of cul1 in the suppression of skp2 expression in quiescent fibroblasts. Embo J 2000;19:5362-5375.
20. Kamura T, Brower CS, Conaway RC, Conaway JW: A molecular basis for stabilization of the von hippel-lindau (vhl) tumor suppressor protein by components of the vhl ubiquitin ligase. J Biol Chem 2002;277:30388-30393.
21. Guardavaccaro D, Kudo Y, Boulaire J, Barchi M, Busino L, Donzelli M, Margottin-Goguet F, Jackson PK, Yamasaki L, Pagano M: Control of meiotic and mitotic progression by the f box protein beta-trcp1 in vivo. Dev Cell 2003;4:799-812. (Pubitemid 36676033)
22. Chen Q, Olashaw N, Wu J: Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase kinase activation pathway. J Biol Chem 1995;270:28499-28502.
23. Bhat NR, Zhang P: Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: Role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death. J Neurochem 1999;72:112-119. (Pubitemid 29013884)
24. Dickinson RJ, Keyse SM: Diverse physiological functions for dualspecificity map kinase phosphatases. J Cell Sci 2006;119:4607-4615. (Pubitemid 44964257)
25. Keyse SM: Dual-specificity map kinase phosphatases (mkps) and cancer. Cancer Metastasis Rev 2008;27:253-261.
26. Owens DM, Keyse SM: Differential regulation of map kinase signalling by dual-specificity protein phosphatases. Oncogene 2007;26:3203-3213. (Pubitemid 46763015)
27. Cardozo T, Pagano M: The scf ubiquitin ligase: Insights into a molecular machine. Nat Rev Mol Cell Biol 2004;5:739-751. (Pubitemid 39208183)
28. Zhou P, Howley PM: Ubiquitination and degradation of the substrate recognition subunits of scf ubiquitin-protein ligases. Mol Cell 1998;2:571-580. (Pubitemid 128379083)
29. Michel MC, Li Y, Heusch G: Mitogenactivated protein kinases in the heart. Naunyn Schmiedebergs Arch Pharmacol 2001;363:245-266.
30. Baines CP, Molkentin JD: Stress signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol 2005;38:47-62. (Pubitemid 40038651)
31. Obata T, Brown GE, Yaffe MB: Map kinase pathways activated by stress: The p38 mapk pathway. Crit Care Med 2000;28:N67-77. (Pubitemid 30262049)
32. Pages G, Berra E, Milanini J, Levy AP, Pouyssegur J: Stress-activated protein kinases (jnk and p38/hog) are essential for vascular endothelial growth factor mrna stability. J Biol Chem 2000;275:26484-26491.
33. Chen CY, Gherzi R, Andersen JS, Gaietta G, Jurchott K, Royer HD, Mann M, Karin M: Nucleolin and yb-1 are required for jnk-mediated interleukin-2 mrna stabilization during t-cell activation. Genes Dev 2000;14:1236-1248. (Pubitemid 30327504)
34. Briata P, Forcales SV, Ponassi M, Corte G, Chen CY, Karin M, Puri PL, Gherzi R: P38-dependent phosphorylation of the mrna decay-promoting factor ksrp controls the stability of select myogenic transcripts. Mol Cell 2005;20:891-903. (Pubitemid 41814878)
35. Schulze PC, Fang J, Kassik KA, Gannon J, Cupesi M, MacGillivray C, Lee RT, Rosenthal N: Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic leftventricular dysfunction. Circ Res 2005;97:418-426. (Pubitemid 41298171)
36. Skurk C, Izumiya Y, Maatz H, Razeghi P, Shiojima I, Sandri M, Sato K, Zeng L, Schiekofer S, Pimentel D, Lecker S, Taegtmeyer H, Goldberg AL, Walsh K: The foxo3a transcription factor regulates cardiac myocyte size downstream of akt signaling. J Biol Chem 2005;280:20814-20823. (Pubitemid 40776786)